Dong-E-E-Jiao Co., Ltd. (SHE:000423)
54.84
+1.28 (2.39%)
Apr 28, 2026, 3:04 PM CST
Dong-E-E-Jiao Revenue
Dong-E-E-Jiao had revenue of 1.81B CNY in the quarter ending March 31, 2026, with 5.52% growth. This brings the company's revenue in the last twelve months to 6.80B, up 5.80% year-over-year. In the year 2025, Dong-E-E-Jiao had annual revenue of 6.70B with 8.83% growth.
Revenue (ttm)
6.80B
Revenue Growth
+5.80%
P/S Ratio
5.18
Revenue / Employee
1.56M
Employees
4,345
Market Cap
35.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.70B | 543.77M | 8.83% |
| Dec 31, 2024 | 6.16B | 1.44B | 30.57% |
| Dec 31, 2023 | 4.72B | 673.45M | 16.66% |
| Jan 1, 2023 | 4.04B | 192.83M | 5.01% |
| Jan 1, 2022 | 3.85B | 439.55M | 12.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Sanjiu Medical & Pharmaceutical | 32.88B |
| Humanwell Healthcare (Group) | 23.96B |
| Beijing Tongrentang | 17.26B |
| Livzon Pharmaceutical Group | 11.71B |
| Changchun High-Tech Industry (Group) | 11.67B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |
| Hubei Jumpcan Pharmaceutical | 5.90B |